Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic Alopecia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-65
SponsorRestore Biologics Holdings, Inc. dba Xtressé
About this trial
The goal of this study is to determine how safe and effective it is to improve hair growth using an active gummy treatment in men with androgenic alopecia.
The main aims of this trial are:
1. To confirm using photographic analysis, changes in the quality, volume, and thickness of hair. 2. To gauge patient satisfaction with hair changes and application process. 3. Monitor and report any adverse events associated with the daily intake of Xtressé
Participants who qualify will complete 3 visits after voluntary consent has been given. Participants will be given a 90-day supply of the gummies at visits 1 and 2 to cover the 6-month study period. Photographs and scalp analysis will be performed at each visit to measure changes in hair volume, thickness, and growth.
Eligibility criteria
Qualifiers
Males aged 18-65
Norwood III to IV, vertex focused
Fitzpatrick skin type I to VI
Ability and willingness to comply with study protocol
Disqualifiers
Change in other hair treatments in 3 months prior to study enrollment.
Known uncontrolled health conditions.
History of hair or scalp disorders that could interfere with study results.
History of metabolic syndrome.
Trial design
Treatments tested in this trial
- Xtressé Hair Growth Gummies
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov